Keywords: KRAS; HNF1β; PIK3CA; PPP2R1A; ARID1A;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: MALDI Imaging; Mass Spectrometry; Molecular Pathology; Pathology Workflow; DNA; desoxyribonuleic acid; EGFR; epidermal growth factor receptor; H&E; hematoxylin and eosin; KRAS; V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog; LC; liquid chromatograph
Keywords: ADAM; a disintegrin and metalloproteinase; AKT; protein kinase B; APAF 1; apoptotic protease activating factor 1; APC; adenomatous polyposis coli; ATG; autophagy protein; BAK; Bcl 2 homologous antagonist/killer; BAX; Bcl-2 associated -X protein; Bcl-2; B-
Keywords: NSCLC; non-small cell lung cancer; RCTs; randomized controlled trials; OS; overall survival; PFS; progression free survival; ORR; objective response rate; AEs; adverse effects; HR; hazard ratio; RR; relative risk; CI; confidence intervals; FDA; Food and D
Keywords: Carcinogenesis; Chemoprevention; Chemotherapy; Oxidative stress; Nrf2; Phytochemicals; AKT; protein kinase B; AMPK; AMP-activated protein kinase; ARE; antioxidant response element; ATF-2; activating transcriptional factor; BBN; N-butyl-N-(4-hydroxybutyl)n
Keywords: NSCLC; Non-Small Cell Lung Carcinoma; SCLC; Small Cell Lung Carcinoma; AC; Adenocarcinoma; LCT; Lung Carcinoid Tumor; LCC; Large Cell Carcinoma; CTC; Circulating Tumor Cells; UICC; The Union for International Cancer Control; CT; Computer-based Tomography;
Keywords: Colorectal cancer; Clinical trials; KRAS; BRAF; Her2; Immunotherapy;
Keywords: Immune Response; Kras; PDAC; Tumorigenesis; ADM; Acinar-ductal metaplasia; AKT; protein kinase B; ERK; extracellular signal-regulated kinase; ESC; embryonic stem cell; GFP; green fluorescent protein; IL; interleukin; IL17R; interleukin 17 receptor; JNK;
Keywords: BRAF; Genomic profiling; KRAS; Mutation; Right colon cancer;
Keywords: Pulmonary adenocarcinoma; Caucasian; EGFR; TP53; KRAS; STK11;
Keywords: Colorectal cancer; Liquid biopsy; KRAS; NRAS; BRAF;
Keywords: ABCB1; ATP-binding cassette sub-family B member 1; ABCG; ATP-binding cassette drug efflux transporters; ACD; autophagic cell death; AKT; alpha serine/threonine protein kinase; ALDH; aldehyde dehydrogenase; AMPK; AMP-activated protein kinase; AP; apurinic/
Keywords: Colorectal carcinoma; Serrated polyp pathway; KRAS; BRAF; CpG island methylator phenotype;
Keywords: ALK; anaplastic lymphoma kinase; CAF; cancer-associated fibroblast; CSC; cancer stem cell; CRC; colorectal cancer; EMT; epithelial-to-mesenchymal transition; EGFR; epidermal growth factor receptor; HH; hedgehog; HGF; hepatocyte growth factor; IGF; insulin
Keywords: Mucinous adenocarcinoma; Mutations; KRAS; STK11; Survival; Never smoker;
Keywords: Pancreatic Cancer; Oncocytic; PanIN; Gastric; Brg1; Brahma Protein-Like 1; IPMN; intraductal papillary mucinous neoplasia; Kras; Kirsten Rat Sarcoma Viral Oncogene Homolog; KrasG12D; LSL-KrasG12D allele; KrasG12D;PtenÎDuct/+; Sox9CreERT2;KrasG12D;Ptenflo
Keywords: MAC; mucinous adenocarcinoma of the salivary gland; CSC; cancer stem cells; PDX; patient-derived xenografts; GEO; gene expression omnibus; TCGA; the cancer genome atlas; Cancer; Salivary mucinous adenocarcinoma; Metastases; Mutations; KRAS; TP53; KDM6A; K
Keywords: EGFR; Epidermal growth factor receptor; TP53; Tumor protein p53; KRAS; Kirsten rat carcoma viral oncogene; ALK; Anaplastic lymphoma kinase; RTK; Protein receptor tyrosine kinase; TKI; Tyrosine kinase inhibitor; PI3K; Phosphatidylinositol 3-kinase; NSCLC;
Keywords: Neuroendocrine Carcinoma; Neuroendocrine tumors; Cancer; Molecular; p53; Microsatellite Instability; APC; Adenomatous Polyposis Coli gene; ATM; Ataxia telangiectasia mutated gene; ATRX; Alpha-thalassemia mental retardation syndrome gene; CASP8; Caspase-8
Keywords: Mucin; Invasive mucinous adenocarcinoma; Lepidic predominant adenocarcinoma; EGFR; KRAS;
Keywords: Polycyclic aromatic hydrocarbon; Kras; Puberty; Ovarian follicles; Mutation; Glutathione;
Keywords: Peritoneal carcinomatosis; Colorectal cancer; HIPEC; MSI; KRAS; Signet ring cell;
Keywords: Adenocarcinoma; Exportin-1; KRAS; Pathway; Selinexor; Targeted therapy; XPO1;
Keywords: ADCC; antibody-dependent cell-mediated cytotoxicity; AKT; protein kinase B; ATP; adenosine triphosphate; cfDNA; circulating free DNA; CISH; chromogenic in-situ hybridization; CTC; circulating tumor cells; EGFR; epithelial growth factor receptor; EMT; epit
Keywords: Liver Cancer; TGFB1; Kras; Zebrafish; α-SMA; α-smooth muscle actin; cDNA; complementary DNA; dox; doxycycline; EGFP; enhanced green fluorescence protein; Gfap; glial fibrillary acidic protein; HCC; hepatocellular carcinoma; HSC; hepatic stellate cell; H
Keywords: NSCLC; ROS1; RET; NTRK; MET; BRAF; KRAS; Driver mutations;
Keywords: Epithelial mesenchymal transition; Grading; KRAS; Microsatellite instability; Prognosis;
Keywords: ATP; adenosine triphosphate; BrP; bromopyruvate; CO2; carbon dioxide; CoA; acetyl-coenzyme A; 2-DG; 2-deoxyglucose; ETC; electron transport chain; FAO; fatty acid oxidation; FAD; flavin adenine dinucleotide; FDG; fluorinated deoxyglucose; FFA; free fatty
Keywords: 3-MA; 3-methyladenine; Asc; ascorbate; ATM; ataxia telangiectasia mutated; ATP; adenosine triphosphate; BRAF; murine sarcoma viral oncogene homolog B; Cat; catalase; Chk2; checkpoint kinase 2; CQ; chloroquine; Cys-SO3H; cysteine S-sulfate; DHA; dehydroasc
Keywords: ADAM; a disintegrin and metalloprotease; ADEX; aberrantly differentiated endocrine exocrine; ALDH1; aldehyde dehydrogenase 1; CAFs; cancer associated fibroblasts; CDKN2A; cyclin dependent kinase inhibitor 2A; CSC; cancer stem cell; CTC; circulating tumor
Keywords: Pancreatic cancer; Genetic mutations; Pancreas; KRAS; TP53
Keywords: FNA; EGFR; KRAS; Adequacy; Small nodules; Non-small-cell carcinoma; Molecular testing;
Keywords: Computed tomography; Imaging; KRAS; Lung neoplasms; Prognosis
Keywords: Biliary tract cancer; Cholangiocarcinoma; Gallbladder cancer; Genomics; Targeted therapy; Kras; Egfr; HER2; FGF; IDH
Keywords: Lung cancer; Somatic alteration; Risk factors; TP53; EGFR; KRAS;
Keywords: Pancreatic cancer; Angiogenesis; Vascular endothelial growth factor (VEGF); ANGPT; angiopoietin; BRAF; serine/threonine-protein kinase B-raf; CAF; cancer associated fibroblast; Cdkn2a; cyclin-dependent kinase inhibitor 2A; CI; confidence interval; CSF1R;
Keywords: Lung carcinoma; Lung adenocarcinoma; EGFR; KRAS; ALK; MET; Histology
Keywords: Kras; Myc; Smad4; Notch; IPMN; intraductal papillary mucinous neoplasm; MSI; microsatellite instability; PARP; poly-ADP-ribose polymerase; PDA; pancreatic ductal adenocarcinoma; PI3K; phosphoinositide 3-kinase inhibitor; TGF; transforming growth factor;
Keywords: Serrated polyp; Traditional serrated adenoma; CIMP; KRAS; BRAF
Keywords: Intratumor heterogeneity; Epidermal growth factor receptor; KRAS; EML4-ALK; Lung cancer;
Keywords: Copy number; Exome sequencing; Germ cell tumor; KIT; KRAS; Somatic mutation; Testicular cancer;
Keywords: Phloroglucinol; Breast cancer stem-like cells; Relapse; Resistance to anticancer treatment; KRAS; Anticancer activity;
Keywords: Anaplastic lymphoma kinase (ALK); Driver oncogene; Epidermal growth factor receptor (EGFR); KRAS; Non–small-cell lung cancer; NRAS; Pemetrexed; ROS1
Keywords: Genetic engineered mouse models; Pancreatic cancer; Kras; Therapeutics; Models of cancer;
Keywords: Anti-cancer therapies; Cancer attractors; Cancer stem cells; Hypoxia; Inflammation; Interactome; Metabolic modeling; Networks; Senescence; Signaling; AKT; RAC-alpha serine/threonine protein kinase; BMI1; polycomb ring finger oncogene; C/EBP; CCAAT/enhance
Keywords: Pancreatic adenocarcinoma; Novel therapeutics; Immunotherapy; BRCA; Stromal targeting; KRAS;
Keywords: Pancreatic cancer; Ductal adenocarcinoma; Neuroendocrine neoplasm; Precursor lesion; Mouse model; KRAS;
Keywords: Pancreatic Cancer; KRAS; Microenvironment; Stroma; Immunomodulation; Autophagy;
Keywords: Antibodies; Immunoconjugates; Immunotoxins; Ab; antibody; Ag; antigen; ADCC; antibody-dependent cell mediated cytotoxicity; ALL; acute lymphoblastic leukemia; AML; acute myeloid leukemia; AKT; protein kinase B; APC; antigen-presenting cell; Apo2L/TRAIL; t
Keywords: Lung cancer; Non-small-cell lung cancer; Never smokers; Epidermal growth factor receptor; EGFR; Anaplastic lymphoma kinase; ALK; KRAS; Tumor genotype; Failure; Bone specimen; Core biopsy; Molecular testing;